Orthopedic Use of BPC 157 Sports Med Review The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BREAKING FDA UPDATE MASSIVE FOR PEPTIDES The U.S. Food & Drug Administration is reportedly reclassifying 14 peptides from Category 2 ( compounding only, no legal prescribing) into Category 1. This means Clinical and Legal Considerations in Pharmaceutical Compounding JCAD The Journal of Clinical and Aesthetic Dermatology Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health